Amgen owes $20.2 million in antibody patent lawsuit, US jury says Amgen subsidiary Teneobio must ‌pay biotech company Harbour Antibodies $20.2 million in damages for infringing a patent related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results